Ravi Potluri

1.1k total citations
77 papers, 774 citations indexed

About

Ravi Potluri is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Ravi Potluri has authored 77 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 25 papers in Hematology and 12 papers in Molecular Biology. Recurrent topics in Ravi Potluri's work include Multiple Myeloma Research and Treatments (13 papers), Acute Myeloid Leukemia Research (13 papers) and Nausea and vomiting management (8 papers). Ravi Potluri is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Acute Myeloid Leukemia Research (13 papers) and Nausea and vomiting management (8 papers). Ravi Potluri collaborates with scholars based in United States, Belgium and United Kingdom. Ravi Potluri's co-authors include Maneesha Mehra, Avinash Desai, Nicole Cossrow, Saad Z. Usmani, Annette Lam, Nikhil C. Munshi, Jessica Vermeulen, Helgi van de Velde, Tahamtan Ahmadi and Jianming He and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Ravi Potluri

67 papers receiving 755 citations

Peers

Ravi Potluri
Kelsey K. Baker United States
Etan Orgel United States
Deirdre R. Pachman United States
Anna Zychlinsky Scharff Germany
A.J. Lehman Canada
Mary Woods United Kingdom
Meghna Jani United Kingdom
Andrew Nicholls United States
Claudio Romani Italy
Judith Löffler‐Ragg Austria
Kelsey K. Baker United States
Ravi Potluri
Citations per year, relative to Ravi Potluri Ravi Potluri (= 1×) peers Kelsey K. Baker

Countries citing papers authored by Ravi Potluri

Since Specialization
Citations

This map shows the geographic impact of Ravi Potluri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Potluri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Potluri more than expected).

Fields of papers citing papers by Ravi Potluri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Potluri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Potluri. The network helps show where Ravi Potluri may publish in the future.

Co-authorship network of co-authors of Ravi Potluri

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Potluri. A scholar is included among the top collaborators of Ravi Potluri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Potluri. Ravi Potluri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stendahl, John C., Sounok Sen, Michael Butzner, et al.. (2025). Health Care Resource Use and Economic Burden in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy and Atrial Fibrillation. Journal of the American Heart Association. 14(17). e038755–e038755.
2.
Komrokji, Rami S., Dylan Supina, Shyamala Navada, et al.. (2025). Transfusion Independence Corresponds With Survival in Patients With Lower-Risk Myelodysplastic Syndrome: Real-World Evidence From United States Insurance Claims. Clinical Lymphoma Myeloma & Leukemia. 25(10). e740–e749.
3.
Regan, Meredith M., Paolo A. Ascierto, Evan J. Lipson, et al.. (2025). Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047. Journal for ImmunoTherapy of Cancer. 13(9). e012747–e012747.
4.
Jairath, Vipul, Tim Raine, Thomas P. Leahy, et al.. (2025). Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis. Journal of Comparative Effectiveness Research. 14(4). e240193–e240193.
5.
Butzner, Michael, Eros Papademetriou, Ravi Potluri, Xing Liu, & Sanatan Shreay. (2024). Differences in Healthcare Resource Use and Cost by Pharmacotherapy Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of Claims Data. American Journal of Cardiovascular Drugs. 24(6). 801–811. 1 indexed citations
6.
Bhagnani, Tarun, et al.. (2024). CTNI-57. REAL-WORLD EVIDENCE OF THE FREQUENCY OF POST-SURGICAL INITIAL OBSERVATION IN PATIENTS WITH IDH-MUTANT GLIOMA. Neuro-Oncology. 26(Supplement_8). viii109–viii110. 1 indexed citations
7.
8.
9.
Smith, Benjamin D., Curtis A. Lachowiez, Alexander J. Ambinder, et al.. (2024). Outcomes By Frailty in IC-Ineligible Newly Diagnosed AML - a Real-World Evidence Comparison By Treatment with Hypomethylating Agents + Ivosidenib or Venetoclax. Blood. 144(Supplement 1). 2855–2855. 1 indexed citations
10.
11.
Schwartzberg, Lee S., Rudolph M. Navari, Kathryn J. Ruddy, et al.. (2023). Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis. Supportive Care in Cancer. 31(11). 654–654. 1 indexed citations
12.
Papademetriou, Eros, Xing Liu, Amélie Beaudet, et al.. (2023). Comparative evaluation of costs and healthcare resource utilization of oral selexipag versus inhaled treprostinil or oral treprostinil in patients with pulmonary arterial hypertension. Journal of Medical Economics. 26(1). 644–655. 2 indexed citations
13.
14.
Potluri, Ravi, et al.. (2022). Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo. BMC Infectious Diseases. 22(1). 769–769. 5 indexed citations
15.
16.
Pesa, Jacqueline, Charmi Patel, David Rotter, et al.. (2021). Economic burden to commercial payers of young adults with schizophrenia in Colorado. Journal of Medical Economics. 24(1). 1194–1203. 1 indexed citations
17.
18.
19.
20.
Potluri, Ravi, et al.. (2015). Treatment Sequencing Patterns And Costs of Care in Patients with Relapsed/Refractory Multiple Myeloma. Value in Health. 18(7). A450–A450. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelsey K. Baker Breakdown of academic impact, for papers by Etan Orgel Breakdown of academic impact, for papers by Deirdre R. Pachman Breakdown of academic impact, for papers by Anna Zychlinsky Scharff Breakdown of academic impact, for papers by A.J. Lehman Breakdown of academic impact, for papers by Mary Woods Breakdown of academic impact, for papers by Meghna Jani Breakdown of academic impact, for papers by Andrew Nicholls Breakdown of academic impact, for papers by Claudio Romani Breakdown of academic impact, for papers by Judith Löffler‐Ragg
Rankless by CCL
2026